The ICON study published in the journal Chest demonstrated a greater than 50% reduction in mortality among hospitalized COVID-19 patients treated with ivermectin

Drug Policy, Pricing & Approval

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

1 debate·7,797 claims·636 news stories

Opening sign-in…